Skip to main content
. 2022 Jan 3;8(1):e08702. doi: 10.1016/j.heliyon.2021.e08702

Table 2.

IC50 (μM) of ARV, LARV, and GALARV in HepG2 and Hep3B liver cancer cells.

Cell line IC50 (μM) of various treatment groups
ARV LARV GALARV
HepG2 0.82 ± 0.11 0.76 ± 0.08 0.52 ± 0.05
Hep3B 0.65 ± 0.24 0.40 ± 0.15 0.38 ± 0.18